U/S SCAN OF TRUS

Hypro Diagnostics employs the transrectal ultrasound scan (TRUS) as a key diagnostic tool for examining the prostate gland, with the option of a TRUS-guided biopsy for tissue sampling. To refine this process, an initial MRI scan is conducted, offering a detailed prostate assessment. This strategic combination of TRUS and MRI enhances the diagnostic precision, guiding Hypro Diagnostics in determining the necessity for a biopsy and optimizing the selection of biopsy sites. This meticulous approach ensures an advanced and accurate evaluation of potential prostate cancer cases.